Split History
SLNO split history picture
Soleno Therapeutics (SLNO) has 2 splits in our SLNO split history database. The first split for SLNO took place on October 06, 2017. This was a 1 for 5 reverse split, meaning for each 5 shares of SLNO owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 200 share position following the split. SLNO's second split took place on August 26, 2022. This was a 1 for 15 reverse split, meaning for each 15 shares of SLNO owned pre-split, the shareholder now owned 1 share. For example, a 200 share position pre-split, became a 13.3333333333333 share position following the split.

When a company such as Soleno Therapeutics conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the SLNO split history from start to finish, an original position size of 1000 shares would have turned into 13.3333333333333 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Soleno Therapeutics shares, starting with a $10,000 purchase of SLNO, presented on a split-history-adjusted basis factoring in the complete SLNO split history. SLNO split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 11/17/2014
End date: 05/23/2024
Start price/share: $303.00
End price/share: $41.17
Dividends collected/share: $0.00
Total return: -86.41%
Average Annual Total Return: -18.92%
Starting investment: $10,000.00
Ending investment: $1,358.50
Years: 9.52
Soleno Therapeutics is a clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutics for the treatment of rare diseases. Co.'s primary candidate is Diazoxide Choline Extended-Release tablets (DCCR), a once-daily oral tablet for the treatment of Prader-Willi Syndrome (PWS). DCCR has orphan designation for the treatment of PWS in the U.S. as well as in the European Union. DCCR tablets consist of the active ingredient diazoxide choline, a choline salt of diazoxide, which is a benzothiadiazine. According to our SLNO split history records, Soleno Therapeutics has had 2 splits.
Date Ratio
10/06/20171 for 5
08/26/20221 for 15
SLNO is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

SLRX Split History
SLS Split History
SLXP Split History
SNBP Split History
SNGX Split History
SNOA Split History
SNPX Split History
SNSS Split History
SONN Split History
SPEX Split History

Also explore: SLNO shares outstanding history

Email EnvelopeFree SLNO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Tharimmune, Inc. (THAR)
BioCardia, Inc. (BCDA)
Lam Research Corporation (LRCX)
Akanda Corp. (AKAN)
Amphenol Corporation (APH)
Jaguar Health, Inc. (JAGX)
OpGen, Inc. (OPGN)
Blue Star Foods Corp. (BSFC)
Charles & Colvard, Ltd. (CTHR)
Seelos Therapeutics, Inc. (SEEL)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

SLNO Insider Buying

SLNO Split History | www.SplitHistory.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Wait! Don't leave yet.
Want to receive our latest research absolutely free?

Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.